InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (2 ops.)
Discover the complete record of transactions filed by Paulson Richard A., Chairman & CEO. Insider active across 1 companies, notably Karyopharm Therapeutics Inc.. Aggregated, 7 filings have been logged. Total volume traded: €17k. The latest transaction was filed on 13 May 2026 (Attribution). Regulator: SEC (Form 4). All data is free.
Declarations7 total
04,920 shares0
Common Stock
SEC:0001193125-26-226613·
04,920 shares0
Common Stock
SEC:0001193125-26-226613:0·
€13,6862,542 shares@ €5.38410.0079% mcap78.6% of flow
Common Stock
SEC:0000899243-22-021477:0·
€3,731633 shares@ €5.89450.0021% mcap21.4% of flow
Common Stock
SEC:0001209191-22-027344:0·
0288,750 shares0
Common Stock
SEC:0001209191-22-014619:0·
0373,200 shares0
Common Stock
SEC:0001209191-21-030166:0·
0373,200 shares0
Common Stock
SEC:0001209191-21-030166·
7 of 7 declarations
About Paulson Richard A.
Richard A. Paulson serves as President and CEO of Karyopharm Therapeutics Inc. He leads the operations of the company, guiding its strategy and growth. His leadership is essential in achieving organizational objectives.
